Jim Simons Celldex Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 181,388 shares of CLDX stock, worth $4.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

181,388

Previous 146,588 23.74%

Holding current value

$4.82 Million

Previous $2.66 Million 38.76%

% of portfolio

0.01%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$15.13 - $21.65 $526,524 - $753,420	34,800 Added 23.74%	181,388 $3.69 Million
Q1 2025 May 14, 2025	BUY	$18.15 - $27.6 $181,500 - $276,000	10,000 Added 7.32%	146,588 $2.66 Million
Q4 2024 Feb 13, 2025	BUY	$23.31 - $32.4 $3.18 Million - $4.43 Million	136,588 New	136,588 $3.45 Million
Q2 2024 Aug 09, 2024	SELL	$32.76 - $42.56 $8.83 Million - $11.5 Million	-269,682 Reduced 86.31%	42,788 $1.58 Million
Q1 2024 May 13, 2024	BUY	$35.22 - $51.88 $11 Million - $16.2 Million	312,470 New	312,470 $13.1 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $587,657 - $972,612	25,888 New	25,888 $728,000
Q4 2021 Feb 11, 2022	SELL	$35.68 - $56.27 $5.75 Million - $9.08 Million	-161,276 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$28.95 - $55.99 $5.87 Million - $11.4 Million	-202,751 Reduced 55.7%	161,276 $8.71 Million
Q2 2021 Aug 13, 2021	SELL	$20.71 - $35.37 $3.67 Million - $6.27 Million	-177,400 Reduced 32.77%	364,027 $12.2 Million
Q1 2021 May 13, 2021	SELL	$16.19 - $29.91 $8.21 Million - $15.2 Million	-507,400 Reduced 48.38%	541,427 $11.2 Million
Q4 2020 Feb 10, 2021	SELL	$14.99 - $22.75 $10.3 Million - $15.6 Million	-687,848 Reduced 39.61%	1,048,827 $18.4 Million
Q3 2020 Nov 13, 2020	BUY	$9.65 - $15.19 $960,175 - $1.51 Million	99,500 Added 6.08%	1,736,675 $25.8 Million
Q2 2020 Aug 13, 2020	BUY	$1.61 - $13.41 $751,850 - $6.26 Million	466,988 Added 39.91%	1,637,175 $21.3 Million
Q1 2020 May 14, 2020	BUY	$1.55 - $3.07 $84,969 - $168,294	54,819 Added 4.91%	1,170,187 $1.94 Million
Q4 2019 Feb 13, 2020	BUY	$2.11 - $2.8 $187,965 - $249,432	89,083 Added 8.68%	1,115,368 $2.49 Million
Q3 2019 Nov 13, 2019	BUY	$2.05 - $2.75 $233,699 - $313,500	114,000 Added 12.5%	1,026,285 $2.19 Million
Q2 2019 Aug 12, 2019	BUY	$2.43 - $5.09 $892,244 - $1.87 Million	367,179 Added 67.36%	912,285 $2.45 Million
Q1 2019 May 14, 2019	BUY	$3.45 - $10.35 $1.88 Million - $5.64 Million	545,106 New	545,106 $2.68 Million

Others Institutions Holding CLDX

# of Institutions

200

Shares Held

68.3M

Call Options Held

219K

Put Options Held

238K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.24B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account